Ductal lavage is an inefficient method of biomarker measurement in high-risk women

Cancer Prevention Research

Volumn 2, Issue 3, 2009, Pages 265-273

  Khan, Seema A ^a   Lankes, Heather A ^a   Patil, Deepa B ^a   Bryk, Michele ^a   Hou, Nanjiang ^a   Ivancic, David ^a   Nayar, Ritu ^a   Masood, Shahla ^b   Rademaker, Alfred ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; DUCTAL LAVAGE; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LAVAGE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MINIMALLY INVASIVE PROCEDURE; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IRRIGATION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; RISK; TAMOXIFEN; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 68349092666     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0119     Document Type: Article

References (24)

1. Bhandare D, Nayar R, Bryk M, et al. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2620-2627 (Pubitemid 41752724)
2. Khan SA, Wolfman JA, Segal L, et al. Ductal lavage findings in women with mammographic microcalcifications undergoing biopsy. Ann Surg 2005;12:689-696 (Pubitemid 41206914)
3. Khan SA, Wiley EL, Rodriguez N, et al. Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst 2004;96:1510-1517 (Pubitemid 39445532)
4. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388 (Pubitemid 28439961)
5. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually [see comments]. J Natl Cancer Inst 1989;81:1879-1886.
6. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994;73:643-651
7. Marshall PN. Papanicolaou staining - a review. Microsc Acta 1983;87:233-243
8. Rosner B, Glynn RJ, Lee ML. Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics 2003;59:1089-1098 (Pubitemid 38021239)
9. Donner A, Klar N. Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol 1994;140:279-289 (Pubitemid 24231914)
10. Battersby S, Robertson BJ, Anderson TJ, King RJB, McPherson K. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 1992;4:601-607
11. Boyd M, Hildebrandt RH, Bartow SA. Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res Treat 1996;37:243-251 (Pubitemid 126422048)
12. Williams G, Anderson E, Howell A, et al. Oral contraceptives (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991;48:206-210
13. Fabian CJ, Kimler BF, Brady DA, et al. A phase II breast cancer chemoprevention trial of oral α-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin Cancer Res 2002;8:3105-3117
14. Fabian CJ, Kimler BF, Zalles CM, et al. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy. Breast Cancer Res Treat 2007;73:643-651
15. O'Shaughnessy JA, Kelloff GJ, Gordon GB, et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002;8:314-346
16. Cazzaniga M, Severi G, Casadio C, Chiapparini L, Veronesi U, Decensi A. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1311-1315 (Pubitemid 44125287)
17. Khan QJ, Kimler BF, Clark J, Metheny T, Zalles CM, Fabian CJ. Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005;14:786-789 (Pubitemid 40478536)
18. Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ. Estrogen receptor expression in benign breast epithelium and breast cancer risk [see comments]. J Natl Cancer Inst 1998;90:37-42.
19. Brogi E, Robson M, Panageas KS, Casadio C, Ljung BM, Montgomery L. Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study. Cancer 2003;98:2170-2176 (Pubitemid 37392420)
20. Visvanathan K, Santor D, Ali SZ, Hong IS, Davidson NE, Helzlsouer KJ. The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavage. Cancer Epidemiol Biomarkers Prev 2006;15:2553-2556 (Pubitemid 46048321)
21. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000;92:1217-1227
22. Visvanathan K, Santor D, Ali SZ, et al. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer-a potential tool for breast cancer risk assessment and biomarker evaluation. Cancer Epidemiol Biomarkers Prev 2007;16:950-955 (Pubitemid 46910097)
23. Arun B, Valero V, Logan C, et al. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 2007;13:4943-4948 (Pubitemid 47294803)
24. Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 2006;97:191-197